Update on bazedoxifene: A novel selective estrogen receptor modulator
Diane M BiskobingDepartment of Medicine, Virginia Commonwealth University, Richmond, VA, USAAbstract: In the elderly population, osteoporosis is a significant clinical problem leading to disability and even death. Many patients remain untreated, despite effective therapies, because of patients&r...
Enregistré dans:
Auteur principal: | Diane M Biskobing |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2007
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7fc97ed35b6f49ffa5f831ab28d3fb65 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
par: Silvia Migliaccio, et autres
Publié: (2007) -
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
par: Kawate H, et autres
Publié: (2011) -
Selective estrogen receptor modulators: tissue specificity and clinical utility
par: Martinkovich S, et autres
Publié: (2014) -
Effect of estrogens on skin aging and the potential role of SERMs
par: Susan Stevenson, et autres
Publié: (2007) -
Rivastigmine in the treatment of Alzheimer's disease: an update
par: Maria Luisa Onor, et autres
Publié: (2007)